« Back
Home /
JNJ 26854165

JNJ 26854165

Manufacturer	Adooq
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	50mg
Item no.	A10491-50
eClass 6.1	30220300
eClass 9.0	32160605
Available
Short Description	JNJ-26854165 is one of p53-activating agents and synergizes with AraC or doxorubicin to induce p53-mediated apoptosis and may provide a novel therapeutic approach for the treatment of acute leukemias.
Cas No	881202-45-5
Synonyms	JNJ26854165, JNJ-26854165
Formula	C21H20N4
Solubilty	DMSO
Purity	>98%
Chemical Name	N-[2-(1H-Indol-3-yl)ethyl]-N'-(4-pyridinyl)-1, 4-benzenediamine
M. Wt.	328, 4
SMILES	C1=CC=C2C(=C1)C(=CN2)CCNC3=CC=C(C=C3)NC4=CC=NC=C4
Storage	2 years at -20C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50mg

available

Delivery expected until 5/23/2024